Category: 4. Health

  • Reclaiming America’s Drug Innovation Edge

    Reclaiming America’s Drug Innovation Edge

    We are on a bureaucratic trajectory where American leadership in approving innovative medicines may not be sustainable and our most experienced pharmaceutical leaders are concerned. Former FDA commissioner Scott Gottlieb recently warned in The Washington Post that pressure from the East threatens to erode our leadership in drug development.

    “As recently as five years ago, American drugmakers had all but shut the door on licensing new medicines from China. By…

    Continue Reading


    News Source: www.forbes.com

  • Why a study claiming vaccines cause chronic illness is severely flawed – a biostatistician explains the biases and unsupported conclusions

    Why a study claiming vaccines cause chronic illness is severely flawed – a biostatistician explains the biases and unsupported conclusions

    At a Senate hearing on Sept. 9, 2025, on the corruption of science, witnesses presented an unpublished study that made a big assertion.

    They claimed that the study, soon to be featured in a highly publicized film called “An Inconvenient Study,” expected out in early October 2025, provides landmark evidence that vaccines raise the risk of chronic diseases in childhood.

    The study was conducted in 2020 by researchers at Henry Ford Health, a health care network in Detroit and…

    Continue Reading


    News Source: theconversation.com

  • Pasteurization destroys H5N1 bird flu in milk

    Pasteurization destroys H5N1 bird flu in milk

    Pasteurization completely inactivates the H5N1 bird flu virus in milk — even if viral proteins linger.

    Drinking properly pasteurized milk contaminated with avian influenza remnants won’t increase vulnerability to the infection, researchers report in September 26 in Science Advances. Heat treatment completely neutralized the highly pathogenic avian influenza H5N1 virus while leaving some viral genomic material intact. Those remnants didn’t make mice sick when they…

    Continue Reading


    News Source: www.sciencenews.org

  • In a first, Huntington’s disease is slowed by an experimental treatment

    In a first, Huntington’s disease is slowed by an experimental treatment

    Even hearing the phrase “Huntington’s disease” will make a room suddenly somber. So the joy that accompanied a recent announcement of results of an experimental gene therapy for the deadly diseases signaled an unfamiliar sense of hope.

    In a small clinical trial, brain injections of a virus that codes for a tiny segment of RNA may have prevented the formation of the rogue proteins that make Huntington’s so devastating. The early results, announced September 24 in a news…

    Continue Reading


    News Source: www.sciencenews.org

  • RFK Jr. Is Targeting Vaccines And Tylenol. Are Prozac And Ozempic Next?

    RFK Jr. Is Targeting Vaccines And Tylenol. Are Prozac And Ozempic Next?

    Tylenol maker Kenvue is reeling after unsupported claims that its popular drug causes autism. Kennedy is unlikely to stop there.

    Tylenol may be only the beginning.

    For years, Robert F. Kennedy Jr. has railed against a number of medications and therapeutics claiming without scientific consensus or evidence that they cause some kind of harm — autism (Tylenol), suicidal thoughts (Ozempic). Now, as President…

    Continue Reading


    News Source: www.forbes.com

  • FDA Approves Injectable Immunotherapy Drug

    FDA Approves Injectable Immunotherapy Drug

    Cancer immunotherapies, anti-cancer treatments that target a patient’s own immune system, working to make it more effective, have revolutionized the field of oncology research over the past decade.  Immune checkpoint inhibitors (ICIs), one class of immunotherapies, work by “blocking” interactions between two proteins (a checkpoint and a ligand).  When a checkpoint protein binds its ligand, the body signals to the immune system, instructing a…

    Continue Reading


    News Source: www.labroots.com

  • Cambridge scientists created a gel that could end arthritis pain

    Cambridge scientists created a gel that could end arthritis pain

    Researchers have developed a material that can sense tiny changes within the body, such as during an arthritis flare-up, and release drugs exactly where and when they are needed.

    The squishy material can be loaded with anti-inflammatory drugs that are released in response to small changes in pH in the body. During an arthritis flare-up, a joint becomes inflamed and slightly more acidic than the surrounding tissue.

    The material, developed by researchers at the University of Cambridge, has…

    Continue Reading


    News Source: www.sciencedaily.com

  • What parents need to know about Tylenol, autism and the difference between finding a link and finding a cause in scientific research

    What parents need to know about Tylenol, autism and the difference between finding a link and finding a cause in scientific research

    Claims from the Trump White House about links between use of the painkiller acetaminophen – often sold under the brand name Tylenol in the U.S. – during pregnancy and development of autism have set off a deluge of responses across the medical, scientific and public health communities.

    As a father of a child with level 2 autism – meaning autism that requires substantial support – and a statistician who works with such tools as those used in the association studies cited by the…

    Continue Reading


    News Source: theconversation.com

  • Trump’s $100,000 H-1B Visa Fee Worsens The U.S. Doctor Shortage

    Trump’s $100,000 H-1B Visa Fee Worsens The U.S. Doctor Shortage

    The American Medical Association and more than 50 other medical societies Thursday asked the Trump administration to exempt physicians from the new $100,000 H-1B visa application fee.

    The White House this week announced that all new H-1B visa petitions would now carry a $100,000 supplemental fee, which the nation’s largest physician group and 53 other medical…

    Continue Reading


    News Source: www.forbes.com

  • Hospitals Lose $32 Billion If Congress Doesn’t Extend ACA Tax Credits

    Hospitals Lose $32 Billion If Congress Doesn’t Extend ACA Tax Credits

    Continue Reading


    News Source: www.forbes.com